Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
نویسندگان
چکیده
منابع مشابه
Three cases of systemic lupus erythematosus and review of the mechanisms concerning treatment with intravenous immunoglobulins (IVIG).
The systemic lupus erythematosus (SLE) is an autoimmune disorder with a broad array of clinical signs. In this research, we aimed to use intravenous immunoglobulins (IVIG) called intacglobin as monotherapy to manage an SLE in three patients. Laboratory investigations for SLE diagnosis were done, including the detection of anti-nuclear antibodies (ANA) and SLE confirmation by detecting high tite...
متن کاملPassive immunotherapy of sepsis with intravenous immune globulin: not all IVIg preparations are created equal
are known to neutralize a wide array of pathogens plus their virulence factors and in addition possess broad antiinfl ammatory and immunomodulating activities. However, these preparations have not been really successful in their present form in preventing sepsis-related death. Th e recent report by the International Neonatal Immunotherapy Study Collaborative Group is the account of the last in ...
متن کاملIntravenous immunoglobulins control scleromyxoedema.
BACKGROUND Scleromyxoedema is a variant of papular mucinosis affecting the skin and internal organs. The different therapeutic approaches proposed for scleromyxoedema are still unsatisfactory. Intravenous immunoglobulin (IVIg) has been successfully employed in the treatment of connective tissue diseases and vasculitides. PATIENTS The successful treatment of three cases of scleromyxoedema with...
متن کاملPattern of intravenous immunoglobulins (IVIG) use in a pediatric intensive care facility in a resource limited setting.
BACKGROUND Intravenous Immunoglobulin (IVIG) preparations are scarce biological products used for replacement or immunomodulatory effects. Guidelines have been issued by regulatory health authorities to ensure provision of the products for patients who are in severe need. OBJECTIVES The study aimed at description of the pattern of IVIG use (label/off label indications), adverse effects observ...
متن کاملProphylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
BACKGROUND In a recently reported study, low doses of intravenous immunoglobulins (IVIG) were shown to be as effective as high doses in protecting chronic lymphocytic leukemia (CLL) patients against infections, although a control group was not included. With this background we started a crossover study of low-dose IVIG prophylaxis aimed at investigating its superiority over empirical treatment ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Immunology and Allergy Clinics of North America
سال: 2008
ISSN: 0889-8561
DOI: 10.1016/j.iac.2008.06.002